Treatment of feline mammary fibroadenomatous hyperplasia with aglepristone

Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/28415

Title:	Treatment of feline mammary fibroadenomatous hyperplasia with aglepristone
Authors:	Uludağ Üniversitesi/Veteriner Fakültesi/Doğum ve Ji̇nekoloji̇ Anabi̇li̇m Dalı. Nak, Deniz Nak, Yavuz Seyrek, Kamil İntaş Kumru, İsmail Hakkı AAH-7292-2019 AAH-5494-2021 9280090000 8615464000 6603409870 16637505700
Keywords:	Veterinary sciences Felidae Felis catus
Issue Date:	Dec-2004
Publisher:	Australian Small Animal Veterinary Assoc
Citation:	Nak, D. vd. (2004). “Treatment of feline mammary fibroadenomatous hyperplasia with aglepristone”. Australian Veterinary Practitioner, 34(4), 161-162.
Abstract:	A case of fibroadenomatous hyperplasia of the mammary gland in a nine-month-old female cat is reported. It was treated with medroxyprogesterone acetate for the suppression of oestrus. Two weeks later. hyperplasia occurred in all mammary glands. The progesterone receptor blocker aglepristone was given sc (10mg/kg) on days 1, 2 and 7. Mammary gland hyperplasia had completely regressed by day 21.
URI:	http://hdl.handle.net/11452/28415
ISSN:	0310-138X
Appears in Collections:	Scopus Web of Science

Files in This Item:

There are no files associated with this item.

DSpace JSPUI